annual cash & cash equivalents:
$151.61M+$7.31M(+5.07%)Summary
- As of today (July 26, 2025), AMPH annual cash & cash equivalents is $151.61 million, with the most recent change of +$7.31 million (+5.07%) on December 31, 2024.
- During the last 3 years, AMPH annual cash & cash equivalents has risen by +$25.26 million (+19.99%).
- AMPH annual cash & cash equivalents is now -2.88% below its all-time high of $156.10 million, reached on December 31, 2022.
Performance
AMPH Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$182.78M+$31.17M(+20.56%)Summary
- As of today (July 26, 2025), AMPH quarterly cash & cash equivalents is $182.78 million, with the most recent change of +$31.17 million (+20.56%) on March 31, 2025.
- Over the past year, AMPH quarterly cash & cash equivalents has dropped by -$18.37 million (-9.13%).
- AMPH quarterly cash & cash equivalents is now -31.49% below its all-time high of $266.78 million, reached on September 30, 2023.
Performance
AMPH quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AMPH Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.1% | -9.1% |
| 3 y3 years | +20.0% | +5.9% |
| 5 y5 years | +105.8% | +233.3% |
AMPH Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.9% | +20.0% | -31.5% | +26.7% |
| 5 y | 5-year | -2.9% | +105.8% | -31.5% | +109.2% |
| alltime | all time | -2.9% | +201.9% | -31.5% | +280.2% |
AMPH Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $182.78M(+20.6%) |
| Dec 2024 | $151.61M(+5.1%) | $151.61M(-21.1%) |
| Sep 2024 | - | $192.12M(+1.3%) |
| Jun 2024 | - | $189.62M(-5.7%) |
| Mar 2024 | - | $201.15M(+39.4%) |
| Dec 2023 | $144.30M(-7.6%) | $144.30M(-45.9%) |
| Sep 2023 | - | $266.78M(+79.5%) |
| Jun 2023 | - | $148.59M(-15.9%) |
| Mar 2023 | - | $176.62M(+13.1%) |
| Dec 2022 | $156.10M(+23.5%) | $156.10M(-0.7%) |
| Sep 2022 | - | $157.24M(-5.4%) |
| Jun 2022 | - | $166.16M(-3.7%) |
| Mar 2022 | - | $172.63M(+36.6%) |
| Dec 2021 | $126.35M(+36.4%) | $126.35M(+18.5%) |
| Sep 2021 | - | $106.61M(+1.1%) |
| Jun 2021 | - | $105.43M(+3.8%) |
| Mar 2021 | - | $101.60M(+9.7%) |
| Dec 2020 | $92.64M(+25.7%) | $92.64M(+5.4%) |
| Sep 2020 | - | $87.91M(+0.6%) |
| Jun 2020 | - | $87.39M(+59.3%) |
| Mar 2020 | - | $54.84M(-25.6%) |
| Dec 2019 | $73.69M | $73.69M(-13.9%) |
| Sep 2019 | - | $85.61M(-28.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $120.37M(+52.2%) |
| Mar 2019 | - | $79.10M(-8.4%) |
| Dec 2018 | $86.34M(+31.6%) | $86.34M(+25.6%) |
| Sep 2018 | - | $68.73M(+43.0%) |
| Jun 2018 | - | $48.07M(-11.9%) |
| Mar 2018 | - | $54.55M(-16.8%) |
| Dec 2017 | $65.59M(-9.3%) | $65.59M(-2.0%) |
| Sep 2017 | - | $66.92M(-18.9%) |
| Jun 2017 | - | $82.54M(+7.5%) |
| Mar 2017 | - | $76.77M(+6.1%) |
| Dec 2016 | $72.35M(+9.5%) | $72.35M(+8.6%) |
| Sep 2016 | - | $66.60M(-0.1%) |
| Jun 2016 | - | $66.66M(+5.3%) |
| Mar 2016 | - | $63.33M(-4.1%) |
| Dec 2015 | $66.07M(-2.6%) | $66.07M(-6.5%) |
| Sep 2015 | - | $70.68M(-5.1%) |
| Jun 2015 | - | $74.46M(+8.6%) |
| Mar 2015 | - | $68.59M(+1.1%) |
| Dec 2014 | $67.83M(+26.6%) | $67.83M(-6.9%) |
| Sep 2014 | - | $72.88M(+13.7%) |
| Jun 2014 | - | $64.08M(+22.9%) |
| Mar 2014 | - | $52.13M(-2.7%) |
| Dec 2013 | $53.59M(+6.7%) | $53.59M |
| Dec 2012 | $50.21M | - |
FAQ
- What is Amphastar Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is Amphastar Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of AMPH is $151.61M
What is the all time high annual cash & cash equivalents for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $156.10M
What is Amphastar Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, AMPH annual cash & cash equivalents has changed by +$7.31M (+5.07%)
What is Amphastar Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of AMPH is $182.78M
What is the all time high quarterly cash & cash equivalents for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $266.78M
What is Amphastar Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, AMPH quarterly cash & cash equivalents has changed by -$18.37M (-9.13%)